The duties of the Remuneration Committee are to:

The HTA Audit Committee is an advisory body to the Human Tissue Authority board (the Authority).

The Authority – the HTA’s non-executive board – is made up of a Chair and 11 Members who are appointed by the Secretary of State for Health, with the exception of one Member appointed by the Welsh Minister and one by the Minister in Northern Ireland.

Find out more about our Board, and other standing committees.

The six-month phase for Human Application sector establishments to comply with new import and export licensing requirements ended on 1 July 2021.

If you import or export tissues and cells between GB and the EEA, you may need a suitable HTA licence in place covering this activity. If you think this applies to you and you have not previously contacted us to discuss your arrangements, please contact us as soon as possible.

The HTA-related licensing changes introduced at the end of the UK Transition Period affect some establishments that previously did not require an HTA licence for importing or exporting human tissues and cells for human application.

Examples of human application include:

Assessment tool to demonstrate that imported tissues and cells meet equivalent standards of quality and safety to those required by the Human Tissue (Quality and Safety for Human Application) Regulations 2007 (as amended) (the Regulations).

For establishments based in NI a third country is defined as:

1. in relation to the import of tissues or cells into NI, a country other than NI or an EEA State; and
2. in relation to the export of tissues or cells from NI, a country other than the UK or an EEA State.

Therefore, if you intend to receive tissues and cells for human application from a supplier based in the EEA, or export tissues and cells for human application to an EEA State or GB, you do not require an import or export licence to do so.